Nuwellis, Inc. (NUWE) Dividend History

Company News

• Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

  Nuwellis reported a 3% increase in revenue for Q1 2025, driven by growth in consumables utilization and higher U.S. console sales. The company also saw a 38% year-over-year increase in pediatric revenue and a 31% reduction in operating expenses.

  GlobeNewswire Inc.
• Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

  Nuwellis, a medical technology company, has finalized an agreement with KDI Precision Manufacturing to outsource the assembly of key Aquadex product components. This strategic relationship is expected to expand Nuwellis' manufacturing capabilities, streamline operations, and enhance the company's ability to deliver high-quality products.

  GlobeNewswire Inc.
• Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights

  Nuwellis, Inc. reported strong financial results for the third quarter of 2024, including a 297% increase in CMS reimbursement, 28% growth in pediatrics revenue, and a 30% reduction in total operating costs. The company continues to see momentum in new account openings and clinical evidence supporting the use of its Aquadex ultrafiltration therapy.

  GlobeNewswire Inc.
• Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  Nuwellis, a medical technology company, announced a $916,000 registered direct offering of its common stock and concurrent private placement of warrants. The company plans to use the proceeds for working capital and general corporate purposes.

  GlobeNewswire Inc.
• SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner - GlobeNewswire

  SeaStar Medical has announced the initial commercial sale of its QUELIMMUNE-Pediatric device to its U.S. partner Nuwellis, Inc. QUELIMMUNE is a patented cell-directed extracorporeal therapy that targets hyperactive immune response in pediatric patients with acute kidney injury and sepsis.

  GlobeNewswire Inc.

  Featured Companies: ICU